Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 1/20 | 0.58 |
| ▸ | TMIGD3 | P0DMS9 | 6/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.51 |
| ▸ | GSK3A | P49840 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | ALDH1A2 | O94788 | 2/20 | 0.45 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.45 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.45 |
| ▸ | AURKA | O14965 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12753191 | 0.85 | ALOX15 (0.55) | DHODHGSK3AGSK3BSMN1; SMN2SIRT2 | |
| SCHEMBL12753158 | 0.81 | DHODH (0.69) | DHODHTMIGD3ADORA3GSK3AMAPT | |
| SCHEMBL12753306 | 0.80 | DHODH (0.54) | DHODHTMIGD3ADORA3GSK3AMAPT | |
| SCHEMBL12753133 | 0.79 | ALDH1A1 (0.60) | DHODHTMIGD3ADORA3GSK3AMAPT | |
| SCHEMBL12753157 | 0.78 | DHODH (0.58) | DHODHTMIGD3ADORA3MAPTSMN1; SMN2 | |
| SCHEMBL12753285 | 0.77 | DHODH (0.51) | DHODHTMIGD3ADORA3GSK3AMAPT | |
| SCHEMBL12753301 | 0.77 | CHRNB2 (0.49) | DHODHTMIGD3ADORA3MAPTSMN1; SMN2 | |
| SCHEMBL12753462 | 0.77 | DHODH (0.51) | DHODHTMIGD3ADORA3MAPTSMN1; SMN2 | |
| SCHEMBL1481133 | 0.77 | DHODH (0.94) | DHODHTMIGD3ADORA3SMN1; SMN2ALDH1A1 | |
| SCHEMBL12753340 | 0.76 | DHODH (0.49) | DHODHTMIGD3ADORA3GSK3AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110077248-A1 | IMIDAZOPYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS | SIRTRIS PHARMACEUTICALS, INC. | 2011-03-31 | — | — | US | disclosed |
| US-20110077248-A1 | IMIDAZOPYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS | SIRTRIS PHARMACEUTICALS, INC. | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110077248-A1 | IMIDAZOPYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS | SIRT3, SIRT1, SIRT2 | DHODH 1141/4885TMIGD3 2683/4885ADORA3 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.